Best Urolithin A for Immune Support
Most of the urolithin A research to date has focused on muscle. A newer thread is more interesting for the immune system: as we age, immune cells accumulate worn mitochondria, and a 2025 randomized trial linked urolithin A to healthier immune-cell mitochondria in midlife adults. This guide separates what that human study actually showed from what is still early, and explains how UA fits as a structure-and-function support option.
Why the immune system and mitochondria are connected
Immune cells are energy-hungry. When they detect a threat, they ramp up activity fast, and that surge is powered by mitochondria, the same energy-producing structures found throughout the body. Two age-related patterns matter here. The first is immunosenescence, the gradual decline in how well the immune system responds. The second is inflammaging, a low-grade, chronic inflammatory tone that tends to rise with age. Research increasingly points to mitochondrial dysfunction inside aging immune cells as one contributor to both, as tired mitochondria can leave immune cells less efficient and more inflammatory.
That connection is why researchers began asking whether an ingredient studied for mitochondrial housekeeping might have anything to offer immune-cell health, and it is the reason urolithin A moved from a purely muscle story into immune research.
What urolithin A is
Urolithin A (UA) is a gut postbiotic. Eating ellagitannin-rich foods, pomegranates, walnuts, and certain berries, gives gut bacteria the raw material to make it, but only some people carry the microbiome needed to produce meaningful amounts. That variability is why supplementing the finished compound has drawn interest. Its studied mechanism is mitophagy: identifying worn-out mitochondria and recycling them so a cell keeps a healthier, more efficient population. Because immune cells depend heavily on mitochondrial performance, this housekeeping process is the logical link between UA and immune-cell health. Our mitochondrial health overview explains the underlying biology.
The human evidence (strongest first)
Here is the honest picture, with the immune-specific trial front and center and animal work kept separate.
The immune-focused human trial
Human: a 2025 randomized controlled trial published in Nature Aging ran for roughly 28 days and reported that urolithin A supported immune-cell mitochondrial health in midlife adults, in the context of inflammaging. This is the study behind the recent coverage connecting UA to immune aging. It is genuine human data, but it is one relatively short trial focused on cellular and mitochondrial markers, not a demonstration that UA reduces infections, illness, or any clinical outcome. Read it as an early, encouraging signal about immune-cell biology rather than proof of an immune-boosting effect.
Established human trials in other areas
Human: the broader human safety and mechanism base comes from muscle-focused work. Andreux and colleagues (Nature Metabolism, 2019) showed UA is safe and well tolerated up to 1,000 mg per day and produced a mitochondrial gene-expression signature. Singh and colleagues (Cell Reports Medicine, 2022) reported improved muscle strength and exercise performance over four months at 500 and 1,000 mg, and Liu, D'Amico and colleagues (JAMA Network Open, 2022) found improved muscle endurance in older adults. These trials do not measure immunity, but they establish that UA is well tolerated at the doses in question and reliably engages mitochondrial biology in humans.
What is still preclinical or early
Preclinical: the foundational work by Ryu and colleagues (Nature Medicine, 2016) showed UA induced mitophagy, extended lifespan in C. elegans, and improved muscle in rodents. Beyond muscle and this new immune signal, early and preclinical research is exploring roles for urolithin A in skin, gut, brain, and heart tissue, but those areas are not established in humans and should be treated as hypotheses, not conclusions. A 2024 systematic review in Ageing Research Reviews concluded that human evidence for targeting aging with urolithin A is still emerging, a fair summary of where the immune thread sits too: one promising 28-day trial, not a body of clinical proof.
How to think about urolithin A for immune support
The responsible framing is narrow. UA is studied for supporting the mitochondrial health of immune cells, a structure-and-function claim, not for preventing colds, fighting infection, or treating any immune condition. It is not a replacement for the fundamentals that actually shape immune resilience with age: sleep, nutrition, physical activity, not smoking, and recommended vaccinations. If those basics are in place and you are interested in mitochondrial support as you move through midlife, UA is a reasonable, evidence-informed add-on.
Practical guidance mirrors the rest of the research: the human trials used 500 to 1,000 mg per day, with 1,000 mg at the top of the studied range, and effects were assessed over weeks to months of daily use. For expectations, see how long urolithin A takes to work, and for the full breakdown see our urolithin A benefits page.
Choosing a urolithin A product
Look for a dose that matches the research (500 to 1,000 mg of actual urolithin A per day), third-party testing for purity and label accuracy, and a format you will take daily. For comparisons, see our best urolithin A gummies roundup and the complete urolithin A guide. You can also review the clinical studies in more detail.
Frequently asked questions
Does urolithin A boost the immune system?
No supplement can honestly claim to boost immunity in a disease sense. A 2025 randomized trial in Nature Aging found urolithin A supported immune-cell mitochondrial health in midlife adults over about 28 days. That is a structure-and-function signal at the cellular level, not evidence that UA prevents illness or infection.
What did the 2025 immune study actually measure?
It was a roughly 28-day randomized controlled trial in midlife adults that assessed markers of immune-cell mitochondrial health in the context of inflammaging. It looked at cellular and mitochondrial outcomes, not clinical endpoints like colds or infections.
Will it stop me getting sick?
No. Urolithin A is not intended to prevent, treat, or cure any illness. Immune resilience with age depends on sleep, nutrition, activity, not smoking, and recommended vaccinations. Talk to your doctor for anything health-related.
What dose was used?
Human urolithin A trials used 500 mg and 1,000 mg per day, with 1,000 mg at the top of the studied range. SOMA HEALTH Urolithin A Gummies provide 1,000 mg in a 4-gummy daily serving.
Is it safe?
In human trials, urolithin A was well tolerated at up to 1,000 mg per day. If you have an immune condition, take immune-affecting medication, are pregnant or nursing, talk with your doctor before starting. See our side effects and safety page.
Can I get enough urolithin A from food?
Only if your gut microbiome converts the ellagitannins in pomegranates, walnuts, and berries into urolithin A, and many people convert little or none. Supplementing the finished compound provides a consistent amount regardless of your microbiome.
How long should I take it before judging results?
The human trials assessed effects over weeks to months of daily use. Urolithin A is a consistency habit, not a quick fix, so give it a sustained run.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →